Pembrolizumab vs Pravastatin

## Pembrolizumab vs Pravastatin: Overview

This comparison examines the pharmacological differences between **Pembrolizumab** and **Pravastatin**.

## Mechanism of Action

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

**Pravastatin**: Competitive inhibitor of HMG-CoA reductase.

## Pharmacokinetics

**Half-life**: Pembrolizumab — 26 days; Pravastatin — 1.8 hours.

## Chemical Properties

**Molecular Formula**: Pembrolizumab — N/A; Pravastatin — C23H36O7.

**Molecular Weight**: Pembrolizumab — N/A; Pravastatin — 424.5280 g/mol.

**Type**: Pembrolizumab — Antibody; Pravastatin — Small molecule.